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Abstract 18 
Receptor recognition and binding is the first step of viral infection and a key determinant of 19 
host specificity. The inability of avian influenza viruses to effectively bind human-like 20 
sialylated receptors is a major impediment to their efficient transmission in humans and 21 
pandemic capacity. Influenza H9N2 viruses are endemic in poultry across Asia and parts of 22 
Africa where they occasionally infect humans and are therefore considered viruses with 23 
zoonotic potential. We previously described H9N2 viruses, including several isolated from 24 
human zoonotic cases, showing a preference for human-like receptors. Here we take a 25 
mutagenesis approach, making viruses with single or multiple substitutions in H9 26 
haemagglutinin and test binding to avian and human receptor analogues using biolayer 27 
interferometry. We determine the genetic basis of preferences for alternative avian 28 
receptors and for human-like receptors, describing amino acid motifs at positions 190, 226 29 
and 227 that play a major role in determining receptor specificity, and several other 30 
residues such as 159, 188, 193, 196, 198 and 225 that play a smaller role. Furthermore, we 31 
show changes at residues 135, 137, 147, 157, 158, 184, 188, and 192 can also modulate 32 
virus receptor avidity and that substitutions that increased or decreased the net positive 33 
charge around the haemagglutinin receptor-binding site show increases and decreases in 34 
avidity, respectively. The motifs we identify as increasing preference for the human-35 
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receptor will help guide future H9N2 surveillance efforts and facilitate our understanding of 36 
the emergence of influenza viruses with increased zoonotic potential. 37 
Importance 38 
As of 2020, over 60 infections of humans by H9N2 influenza viruses have been 39 
recorded in countries where the virus is endemic. Avian-like cellular receptors are the 40 
primary target for these viruses. However, given that human infections have been detected 41 
on an almost monthly basis since 2015, there may be a capacity for H9N2 viruses to evolve 42 
and gain the ability to target human-like cellular receptors. Here we identify molecular 43 
signatures that can cause viruses to bind human-like receptors, and we identify the 44 
molecular basis for the distinctive preference for sulphated receptors displayed by the 45 
majority of recent H9N2 viruses. This work will help guide future surveillance by providing 46 
markers that signify the emergence of viruses with enhanced zoonotic potential as well as 47 
improving understanding of the basis of influenza virus receptor-binding.  48 
 49 
Introduction 50 
In the 1990s avian influenza virus subtypes H5N1 and H9N2 underwent a host-switch 51 
from wild birds to domestic poultry where they have circulated ever since. H9N2 has since 52 
become one of the most widespread strains in poultry, infecting domestic fowl throughout 53 
Asia and North Africa, where it circulates hyper-endemically (1-4). Zoonotic H9N2 cases are 54 
also occasionally detected, with human infections reported in Hong Kong, mainland China, 55 
Bangladesh, Egypt, Pakistan, Oman, India and Senegal; over half of human infections have 56 
been reported in the last 4 years alone, all of which indicates a growing pandemic threat 57 
from these viruses (4-12). Although no human-to-human transmission has been recorded, 58 
some H9N2 virus strains have shown a high propensity for airborne transmission between 59 
ferrets (13, 14), the most commonly used model for human influenza transmission. 60 
The haemagglutinin (HA) glycoprotein mediates attachment of influenza viruses to 61 
host cells through binding of glycans with terminal sialic acid moieties. The human upper 62 
respiratory tract (URT) is rich in glycans with terminal α2,6-linked sialic acid (SA) and is the 63 
primary site of replication for human influenza viruses. An important determinant for 64 







Genetic basis of H9N2 receptor-binding variability 
3 
 
adaptation to the human URT is the ability of HA to bind α2,6-linked sialylated glycans (15). 65 
However, most avian influenza viruses preferentially bind to glycans with terminal α2,3-66 
linked SAs, which are common in the avian gastrointestinal and respiratory tracts (16). 67 
Therefore, for avian influenza viruses to be able to efficiently infect and transmit between 68 
humans they must gain the ability to bind to α2,6-linked SA. Furthermore, contemporary 69 
chicken-adapted H9N2 and H6N1 (Taiwanese lineage) viruses have specifically been 70 
identified as having a receptor preference for α2,3-linked SA, sulphated on the 71 
antepenultimate sugar, while highly pathogenic H5, H7 as well as low pathogenicity avian 72 
influenzas viruses from waterfowl appear to bind sulphated and non-sulphated α2,3-linked 73 
SA equally well (17-25). 74 
Several molecular determinants have been shown to influence the receptor-binding 75 
profile of H9N2 viruses, including position 226 (H3 HA numbering used throughout; position 76 
216 in mature polypeptide H9 numbering) – in one strain, the Q226L substitution alone 77 
could facilitate greater replication of an H9N2 isolate in human epithelial airway cells (26). 78 
Substitutions at 155, 190 and 227 (145, 180 and 217 in H9 numbering) have also been 79 
shown to play a role in receptor-binding preference in some H9N2 viruses (13, 17, 27, 28). 80 
However, understanding of H9N2 receptor-binding preference remains piecemeal, with no 81 
studies having systematically looked at the roles of multiple residues singly and in 82 
combinations. 83 
In a previous study, we described notable variability in receptor-binding preference 84 
amongst circulating H9N2 viruses which we hypothesised was due to amino acid variability 85 
at residues 190, 226 and 227 (18). Here, we take three H9N2 viruses representative of 86 
different receptor-binding profiles, including a virus isolated from a human with a natural 87 
preference for α2,6-linked SA, and generate recombinant virus libraries with HA amino acid 88 
substitutions that represent reciprocal changes at each non-conserved amino acid position 89 
in the vicinity of the receptor-binding site between the progenitor H9N2 viruses. We test the 90 
receptor-binding of these libraries using biolayer interferometry (BLI) and show that 91 
changes at residues 190, 226, 227, and to a lesser extent 159, 188, 193, 196, 198, and 225, 92 
explain this receptor preference variability. We further show several antibody escape 93 
mutants have changed receptor preference or avidity, and we describe a correlation 94 
between the electrostatic charge of the HA head and receptor avidity. Finally, we use the 95 
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insights from these experiments to predict H9N2 lineages within the general viral population 96 
that have enhanced propensity to bind human receptors and therefore possess a higher 97 
zoonotic potential. 98 
Results 99 
Three previously characterised H9N2 viruses were chosen to act as mutagenesis 100 
backgrounds due to their distinct receptor-binding phenotypes (18). Receptor-binding 101 
profiles were measured using BLI with three receptor analogues: sulphated and non-102 
sulphated 3’sialyllactosamine (3SLN(6su) and 3SLN, respectively) and 6’sialyllactosamine 103 
(6SLN). Both 3SLN(6su) and 3SLN are analogues for avian-like receptors while 6SLN is an 104 
analogue for human-like receptors. The virus A/chicken/Pakistan/UDL-01/2008 (UDL1/08) 105 
displays high binding avidity to 3SLN(6su), but not 3SLN (avian-like), with residual binding to 106 
the human-like receptor 6SLN (Figure 1A), similar to the majority of contemporary H9N2 107 
viruses (17-19). The virus A/chicken/Emirates/R66/2002 (Em/R66) binds to both 3SLN(6su) 108 
and 3SLN but has no detectable binding to 6SLN (Figure 1B), similar to conventional avian-109 
adapted H5N1 and H7 viruses (18, 23). Finally, A/Hong Kong/33982/2009 (HK/33982) binds 110 
to all three receptor analogues, but with an appreciable preference for human-like 6SLN, 111 
similar to early human pandemic H3N2 viruses and zoonotic H7N9 viruses (Figure 1C) (18, 112 
24). To test the molecular basis of these different receptor preferences, libraries of 113 
individual or multiple reciprocal mutants were generated between these viruses with a 114 
particular focus on positions 190, 226 and 227, as well as several other nearby receptor 115 
binding site (RBS) residues. 116 
Molecular basis of preference for sulphated and non-sulphated avian receptors 117 
To explore the molecular basis of the preference of many contemporary H9N2 for 118 
sulphated avian receptors, a property not shared with non-H9N2 avian influenza viruses, we 119 
investigated amino acid differences between UDL1/08 and Em/R66, which do and do not 120 
show this preference respectively (17, 18, 20). Generally, these viruses had few differences 121 
near the RBS, though they did differ at the positions 190, 226, and 227 to which 122 
substitutions were introduced singly and in combination (Figure 1D). 123 
Substituting all three variable RBS residues (190/226/227) led to an approximate 124 
switch of the receptor-binding phenotypes. This increased UDL1/08 3SLN binding and 125 
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eliminated its 6SLN binding and abolished Em/R66’s 3SLN binding while increasing its 6SLN 126 
binding (Figure 2, purple lines). Generally, 190/226 reciprocal mutants expressed similar 127 
phenotypes to the triple mutants (Figure 2, brown lines), suggesting L227I and I227L had 128 
only a modest influence. The exception to this was that Em/R66 E190A/Q226L/L227I did not 129 
show the increased binding to 6SLN observed with Em/R66 E190A/Q226L (Figure 1E). 130 
However, in each case the exact binding avidities to the three receptor analogues were not 131 
completely recapitulated; both triple mutants had reduced avidity compared to their wild-132 
type parental viruses indicating that further substitutions are required to fully recover the 133 
receptor-binding profile of the donor viruses. Nonetheless, positions 190, 226, and to a 134 
lesser extent, 227 appeared to be the primary determinants of variation in receptor-binding 135 
preference phenotypes of UDL1/08 and Em/R66s (Table 1). 136 
Considering single residues, substitutions at position 190 exerted a strong influence 137 
on the preference for sulphated or non-sulphated avian-like receptors (3SLN(6su) and 3SLN, 138 
respectively); viruses with A190 showed increased binding to 3SLN(6su) and decreased 139 
binding to non-sulphated 3SLN analogues while those with E190 showed the opposite 140 
(Figure 2A,C,D,F). This is potentially due to a charge repulsion between the negatively 141 
charged side-chain of glutamate and the sulphate group of 3SLN(6su). Additionally, viruses 142 
containing A190 generally retained or had enhanced human-like 6SLN binding as seen in 143 
UDL1/08 wild-type and the mutants Em/R66 E190A and Em/R66 E190A/Q226L (Figure 2B,E). 144 
This was also exemplified in the differences in binding between UDL1/08 mutants: 145 
A190E/L226Q led to a loss of 6SLN binding while L226Q alone did not (Figure 1B – mint and 146 
brown lines). 147 
At position 226, we determined that substitutions were exerting an effect on 148 
receptor-binding avidity, consistent with the results of our previous work with erythrocyte-149 
based avidity assays (29). Viruses with Q226 bound with higher avidity, compared with L226, 150 
to each of the three analogues tested (Figure 2A-F). Additionally, Q226 favoured 3SLN 151 
binding as can be seen by the mutant UDL1/08 L226Q and the difference in avidity between 152 
Em/R66 E190A/Q226L and E190A alone (Figure 2C,F – blue and brown lines). In the 153 
background of Em/R66, Q226L showed a large increase in 6SLN binding (Figure 2E – mint 154 
line), however a matching reduction in 6SLN binding by UDL1/08 L226Q was not seen 155 
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(Figure 2B), indicating this is probably dependent on the context of the other amino acids in 156 
the H9 HA RBS as we had previously predicted (18). 157 
Finally, substitutions at position 227 were identified as playing a minor role in 158 
modulation of avidity, though did not change receptor preference or regulate complete gain 159 
or loss of binding to any analogue. Relative to the parental virus, UDL1/08 I227L showed 160 
higher avidity to all receptors while Em/R66 L227I showed lower avidity (Figure 2, orange 161 
lines), consistent with previous inferences made from indirect avidity measurements (29). 162 
Molecular basis of preference for the human receptor 163 
We next investigated the molecular basis of human-like receptor-binding expressed 164 
by some H9N2 viruses. A reciprocal library was generated between UDL1/08, which 165 
expresses a preference for the sulphated avian-like receptor (3SLN(6su)), and HK/33982, a 166 
virus from a human H9N2 case that binds strongly to the human-like receptor (6SLN) with 167 
moderate binding to both avian-like receptors (Figure 1). The amino acids at the three 168 
residues shown above to largely determine preference for sulphated vs non-sulphated (190, 169 
226, and 227) also vary between these two viruses. In addition to these three positions, 170 
reciprocal mutations were introduced at positions 188 and 193 (178 and 183 in H9 171 
numbering) on the basis that these residues are located next to the binding site and vary 172 
between UDL1/08 and HK/33982 (Figure 1E). 173 
Introducing the substitutions A190D, L226Q and I227Q from HK/33982 into UDL1/08 174 
led to a loss of most of its 3SLN(6su) binding and a slight gain in 6SLN binding (Figure 3A, B, 175 
purple lines), however this binding phenotype did not resemble that of HK/33982. This 176 
suggests additional substitutions are required for a full gain of the human-adapted receptor-177 
binding profile. The reciprocal triple mutant was unable to be recovered in the HK/33982 178 
background, indicating additional residues must play a role in stabilising residues 190, 226 179 
and 227 between these two viruses (Table 2).  180 
Introduction of reciprocal substitutions at residues 190 and 227 together indicated 181 
that these positions likely play an important role in modulation of preference between the 182 
3SLN(6su), and 6SLN receptor analogues. UDL1/08 with A190D/I227Q showed slightly 183 
decreased binding to 3SLN(6su) and appreciably increased 6SLN binding (Figure 3A,B – grey 184 
lines). HK/33982 D190A/Q227I had reduced receptor-binding to 6SLN and increased binding 185 
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to 3SLN(6su), creating an approximation of the receptor-binding preference of wild-type 186 
UDL1/08 (Figure 3D,E – grey lines). From this mutant library it is clear that switches at 187 
position 226 create an incompatibility in both virus backgrounds, with several viruses losing 188 
nearly all receptor-binding (UDL1/08 A190D/L226Q and A190D/L226Q/I227Q) or infectious 189 
virus unable to be rescued entirely (HK/33982 D190A/Q226L and D190A/Q226L/Q227I; see 190 
Table 2). This was consistent with our previous work where we saw a number of reciprocal 191 
mutants in HA required compensatory changes, or mutants rapidly reverted upon successful 192 
rescue (29). 193 
Concerning single amino acid substitutions, amino acid substitutions at residue 190 194 
in the single reciprocal mutants of UDL1/08 and HK/33982 showed potential 195 
incompatibilities. UDL1/08 A190D showed a mixed population also including 190G while 196 
HK/33982 D190A gained the additional substitution G225D, as previously described (29). 197 
HK/33982 D190A/G225D increased 6SLN binding and 3SLN(6su) binding while decreasing 198 
3SLN binding, similar to Em/R66 E190A (Figure 3D-F – blue lines). However, HK/33982 with 199 
the G225D substitution alone was also unable to produce infectious virus complicating 200 
interpretation of the influence of these mutations. UDL1/08 A190D/G showed no difference 201 
in binding compared to UDL1/08 (Figure 2A-C – blue lines), however it is difficult to interpret 202 
these data, given the mixed population. 203 
Similar to the reciprocal mutants of UDL1/08 and Em/R66, amino acid substitutions 204 
at residue 226 between UDL1/08 and HK/33982 displayed a clear avidity effect, with 226L 205 
appearing to confer higher avidity compared with 226Q. HK/33982 with Q226L gained the 206 
additional compensatory substitution H184E (Table 2); HK/33982 with H184E alone showed 207 
a large reduction in avidity to all receptor analogues, whereas HK/33982 with H184E/Q226L 208 
increased avidity to both 6SLN and 3SLN(6su) relative to H184E alone, suggesting Q226L 209 
increased binding avidity (Figure 3D-F – purple and mint lines, Table 3). The mutant 210 
HK/33982 H184E/Q226L also showed a strong preference for 6SLN.  211 
At position 227, the virus UDL1/08 I227Q showed a large increase in 6SLN binding, a 212 
drop in binding to UDL1/08’s preferred receptor 3SLN(6su), and did not alter binding to 213 
3SLN (Figure 3A-C, orange lines). The reciprocal mutant, HK/33982 Q227I, showed a general 214 
avidity effect with lower binding to all analogues (Figure 3D-F – orange line). When 215 
introduced alongside D190A, the impact of Q227I in the HK/33982 D190A/Q227I double 216 
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mutant reduced 6SLN binding and slightly increased 3SLN(6su), relative to the parental wild-217 
type and the D190A(+G225D) mutant (Figure 3D-F – grey and orange lines). 218 
Reciprocal substitutions at position 188 influenced receptor-binding while those at 219 
position 193 did not. These residues have not previously been described as affecting 220 
receptor-binding in H9 HA, though they are adjacent to the RBS and 193 has been described 221 
as playing a vital role in the modulation of binding of sulphated 3SLN by H5 and H7 HA (30, 222 
31). Viruses with Y188 showed higher avidity relative to viruses with D188, regardless of the 223 
virus background (Figure 3 – red lines). Additionally, HK/33982 Y188D appeared to have 224 
minor effects on specific receptor analogue preference with a greater reduction in 3SLN 225 
binding compared with 6SLN. Amino acid swaps at position 193 showed a very minor, non-226 
reciprocal receptor preference effect (Figure 3). 227 
Molecular basis of variation in receptor-binding avidity 228 
 In addition to showing preference for different receptors, influenza viruses vary in 229 
receptor-binding avidity. In previous studies we have inferred that escape mutants with the 230 
largest impact of polyclonal antisera binding may be driven by avidity effects (17, 29, 32). To 231 
further investigate the genetic basis of variation in receptor-binding avidity we constructed 232 
a library of mutants in the UDL1/08 background, many of which we had previously identified 233 
as modulating virus antigenicity (29), and assessed their receptor-binding phenotypes. To 234 
complement this, we analysed a large dataset of haemagglutination inhibition (HI) titres and 235 
HA sequences from natural H9N2 viruses to identify amino acid variants correlating with 236 
avidity effects apparent in measured titres. 237 
Testing of UDL1/08 mutants showed several exhibited a general decrease in avidity 238 
to the tested analogues including K137I, F147L, K157T, N158D, N193D, and G225D (Figure 239 
4A,B). A single substitution, T189N, showed a negligible effect on receptor-binding (Figure 240 
4C,D - mint lines). Two substitutions, T135K and T192R, appeared to increase avidity (i.e. 241 
increased binding to all analogues tested) in a similar manner to UDL1/08 I227L and D188Y 242 
from the reciprocal mutant libraries (Figure 4C,D, 2A-C and 3A-C). The substitution R82G 243 
showed a reduction in 3SLN(6su) binding without affecting 6SLN binding (Figure 4E,F – blue 244 
lines). Finally, one group of mutants showed changes in receptor-binding preference with 245 
increases in human-like 6SLN binding relative to sulphated avian-like receptor 3SLN(6su): 246 
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I227M showed a large increase in 6SLN binding without changing 3SLN(6su) binding (orange 247 
lines); G159K showed a modest increase in avidity to 3SLN(6su) but a much larger relative 248 
increase in 6SLN binding (purple lines); T196I, T196K, and T198A all decreased 3SLN(6su) 249 
binding while increasing 6SLN binding to varying degrees (Figure 4E,F – light red, dark red 250 
and light brown lines). This last group of mutations represent single amino acid changes that 251 
could act as markers for viruses with greater zoonotic potential, along with the previously 252 
described Q226L (in the background of Em/R66 and HK/33982), and I227Q in a UDL1/08-like 253 
background (Figure 2E, 3B,E). 254 
In general, amino acid replacements that increased positive charge in the HA head 255 
domain tended to cause an increase in receptor-binding avidity while the opposite was true 256 
for substitutions that increased negative charge. In Figure 5A, the impact of substitutions 257 
introduced to the UDL1/08 backbone on avidity for its preferred receptor, 3SLN(6su), is 258 
plotted by the change in net charge of the HA head domain. The proximity of the residues at 259 
which substitutions were introduced to the RBS is shown in Figure 5B.  260 
To investigate variation in avidity among natural H9N2 viruses, we modelled 261 
variation in HI titres for a dataset of large number of viruses covering all major H9 lineages. 262 
In addition to measuring antigenic relationships, HI titres are influenced by avidity. Viruses 263 
with higher avidity require more antibodies to inhibit haemagglutination manifesting as a 264 
tendency towards lower HI titres regardless of antigenic relationships to the antisera used, 265 
and vice-versa. To identify amino acid variants correlating with such variation in titres, we 266 
adapted a model we previously developed to identify molecular determinants of antigenic 267 
variation in both human and avian influenza viruses (29, 33). 268 
Variation in HI titres resulting from antigenic differences and from variation in virus 269 
avidity was mapped to branches of the HA phylogenetic tree as previously described (29). To 270 
explore the genetic basis of variation caused by differences in avidity, phylogenetic terms 271 
representing branches leading to clades of viruses with systematically higher or lower titres 272 
were replaced with terms representing amino acid identity in the test virus at each variable 273 
HA position in turn. Under a forward selection procedure, amino acids at positions 190, 196 274 
and 198 were identified as contributing to variation in avidity. Each of these positions are in 275 
the 190-helix, proximal to the RBS. Position 190 has already been shown to play a role in 276 
receptor-binding in this and other studies (17, 27), and we see the effect of 196 and 198 on 277 
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receptor-binding preference in this study (Figure 4E,F), further validating this modelling 278 
approach (Table 4). 279 
Sequence-based prediction of receptor-binding preference of H9N2 viruses 280 
 Finally, we extrapolated the BLI results with the 3SLN, 3SLN(6su) and 6SLN receptor 281 
analogues to predict receptor-binding preferences of circulating H9N2 viruses on the basis 282 
of amino acid identity at positions 190, 226 and 227 according to Table 5. Viruses were 283 
predicted as possessing one of three receptor-binding phenotypes: 1) a strong preference 284 
for sulphated avian-like receptors, typical of chicken-adapted H9N2 viruses, 2) a receptor-285 
binding phenotype more similar to chicken-adapted H5Nx or H7N1 viruses that binds both 286 
sulphated and non-sulphated avian-like receptors, or 3) a preference for the human-like 287 
receptor with concurrent binding to avian receptors. Amino acid identity at positions 190, 288 
226 and 227 and the resulting prediction is shown across a phylogeny constructed using all 289 
available H9N2 HA sequences in Figure 6. Almost all viruses in the Y439-like lineage, 290 
prevalent in wild birds and in poultry in Korea, as well as a few viruses in the G1-Eastern 291 
sub-lineage are predicted to show an Em/R66-like preference for any avian-like receptor. 292 
The vast majority of viruses in the chicken-adapted BJ94 and G1 lineages are predicted to 293 
express a sulphated avian receptor preference. A significant number of viruses belonging to 294 
the G1-Eastern sub-lineage, prevalent in minor poultry in China, are predicted to show a 295 
preference for human-like receptors, as are a number of viruses interspersed within a clade 296 
of viruses belonging to the BJ94 lineage. 297 
Discussion 298 
Receptor-binding is an important determinant of host specificity and modification of 299 
receptor binding properties is often a critical step in cross-species virus transmission. In this 300 
study we have comprehensively investigated residues in and around the receptor binding 301 
site (RBS) of HA from H9N2 viruses for their ability to influence receptor preference and 302 
avidity. We have shown that different combinations of the residues 190, 226 and 227 303 
account for much, but not all, of the variability in H9N2 receptor binding between viruses 304 
representative of the major binding phenotypes. Furthermore, we described several other 305 
residues that have strong influences on H9N2 receptor binding preference including 306 
positions 159, 188, 193, 196 and 198. We propose a model whereby residues in the 307 
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influenza HA1 that don’t directly coordinate receptor binding can play a delocalised avidity 308 
role through modulating the charge of the head domain with increases in positive charge 309 
giving a non-specific increase in avidity and vice versa. We hypothesise this effect may be 310 
exaggerated for H9N2 viruses where sulphated, siaylated glycans appear to be the preferred 311 
receptor owing to the greater amount of negative charge in these receptors (compared to 312 
non-sulphated, siaylated glycans). Finally, we have applied the results of this study to try 313 
and predict the receptor binding phenotypes of different circulating H9N2 viruses as a way 314 
of predicting strains that may have a heightened zoonotic potential. 315 
Several of the residues identified in this study have been previously described as 316 
directly or indirectly affecting H9 receptor binding, including position 155, 190, 225, 226 and 317 
227 (13, 17, 26-28, 34, 35). In previous studies, generally only one or two of these residues 318 
are measured in isolation for their receptor binding effect or are tested in a non- or only 319 
semi-quantitative manner. Here we perform a comprehensive, quantitative analysis often 320 
testing changes at residues in multiple different virus backbones and in multiple 321 
combinations to investigate strain-specific and compensatory effects. For example, the 322 
substitution Q226L has been shown several times in an older G1-Eastern lineage virus to 323 
increase binding to human-like receptors (26, 36), with a similar effect when we investigate 324 
a contemporary virus of the same lineage (i.e. HK/33982). However in a G1-Western 325 
backbone (i.e. UDL1/08) we find a completely different effect whereby there is a general 326 
avidity increase and an overall increase in 6SLN-binding when a L226Q substitution is 327 
incorporated, highlighting the importance of the context in which a mutation occurs.  328 
In a previous study, we inferred that several substitutions that had the largest effect 329 
on immune escape in H9N2 viruses were substitutions that affect avidity, as has been 330 
predicted for human influenza viruses (29, 37, 38). Here we demonstrated that a wide 331 
variety of escape mutants previously shown to robustly modulate polyclonal antisera 332 
binding do indeed modulate receptor-binding avidity, indicating elevation of avidity to be a 333 
viable mechanism of immune escape for H9N2 viruses as has been shown for human 334 
influenza viruses (37, 38). We also performed an analysis of matched genetic and antigenic 335 
data for 330 H9N2 viruses, covering each major H9 lineage (29). This identified that different 336 
amino acids at positions 190, 196 and 198 contributed to variation in HI titres as a result of 337 
differing avidity, as they tended to be associated with lower or higher titres after accounting 338 
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for antigenic similarity to the antisera used. We also confirmed each of these three positions 339 
play an important role in regulation of receptor-binding avidity using BLI, validating this 340 
approach and indicating that BLI results are transferable to observations based on 341 
erythrocyte-binding. In addition to the important role for 190 in receptor preference, the 342 
substitutions T196I, T196K and T198A all showed relative increases in human-like receptor 343 
binding. These results further support the case for using integrated modelling approaches to 344 
reanalyse large data sets and predict genotype-phenotype relationships. 345 
We present evidence suggesting that residues in the influenza HA1 that don’t 346 
directly coordinate receptor binding play a delocalised avidity role through modulating the 347 
charge of the head domain. For mutations introduced in the UDL1/08 background and 348 
measured in binding to its preferred receptor, 3SLN(6su), we found a significant trend in 349 
avidity change between substitutions that introduced a negative charge and those that 350 
introduced a positive charge. In general, substitutions observed to increase avidity tended 351 
to increase the net positive charge around the RBS (e.g. T135K, G159K, T192R, D188Y, 352 
Em/R66 E190A, Em/R66 Q226L/E190A) whilst avidity decreasing mutants usually decreased 353 
the net positive charge around the RBS (e.g. R82G, K137I, K157T, N158D, N193D, G225D, 354 
HK/33982 Y188D, HK/33982 H184E). This effect is likely due to non-specific charge 355 
interactions with the negatively charge sialic acid and we hypothesise may be more 356 
pronounced for H9N2 viruses as the negative charge of sulphated, siaylated glycans, which 357 
appear to be their preferred receptor, is greater due to the negatively charged sulphate 358 
group. 359 
An important contribution of this study is the identification of several substitutions 360 
that, in one or more of our virus backbones, resulted in viruses with increased or de novo 361 
human-like 6SLN binding. These residues will be useful for future surveillance efforts to 362 
identify newly sequenced viruses with elevated zoonotic potential. These particular 363 
substitutions include the previously well characterised Q226L substitution in HK/33982 or 364 
Em/R66-like backbones (but not the contemporary G1-Western UDL1/08-like backbone) as 365 
well as the newly characterised R82G, T135K, G159K, T196I, T196K, T198A, I227M and 366 
I227Q substitutions in the UDL1/08-like backbone. Although further work using whole virus 367 
in biologically relevant tissue types such as human airway epithelial cells or lung organoids 368 
would be desirable to fully verify our biophysical receptor binding results. Several of these 369 
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mutations are already commonly found in the field, further suggesting that H9N2 virus 370 
variants naturally circulate with a likely heightened zoonotic potential. In particular, a 371 
significant proportion of viruses belonging to the G1-Eastern sub-lineage, prevalent in minor 372 
poultry in China are predicted to show a preference for human-like receptors representing a 373 
zoonotic risk. We hypothesise that the enhanced preference for the human-like receptor 374 
could be an adaptation to minor poultry which over-express α2,6-linked SA, relative to 375 
chickens. 376 
In conclusion, we have quantified the impact of single and multiple amino acid 377 
substitutions on receptor binding phenotypes in the context of several H9N2 viruses with 378 
varying receptor binding preferences, identifying seven novel mutations that increase 379 
binding to the human-like receptor. We further highlight the importance of mutations that 380 
impact receptor binding avidity. Avidity modulation has a dramatic impact on antigenicity 381 
and an equally important role in receptor binding phenotype, thus viruses that gain avidity 382 
enhancing mutations may present multiple challenges in that both vaccine efficacy may be 383 
compromised, and zoonotic potential may be increased concurrently. As well as helping 384 
better understand the molecular basis of avian influenza receptor binding, the results 385 
generated here will help future surveillance efforts to identify viruses which may potentially 386 
have an augmented zoonotic potential and/or greater vaccine escape potential. 387 
Materials and Methods 388 
Ethics statement 389 
Use of embryonated eggs in this study was carried out in strict accordance with 390 
European and United Kingdom Home Office regulations and the Animals (Scientific 391 
Procedures) Act 1986 Amendment Regulations, 2012. These studies were carried out under 392 
the United Kingdom Home Office approved project license numbers P68D44CF.  393 
Cell lines and eggs 394 
HEK 293Ts and MDCKs were maintained in Dulbecco’s modified Eagle medium 395 
(DMEM), supplemented with 10% foetal calf serum (FCS), 37oC, 5% CO2. Viruses were 396 
propagated in 10-day-old embryonated eggs; allantoic fluid was harvest 48 hours post-397 
inoculation. 398 











Throughout this study recombinant viruses, generated by standard 8 plasmid 400 
influenza reverse genetics were used using HEK 293T/MDCK co-culture (39). All viruses 401 
contained the named HA gene (whether wild type or mutant), the NA of 402 
A/chicken/Pakistan/UDL-01/2008 (UDL1/08) and the remaining genes from A/Puerto 403 
Rico/8/1934 (PR8), allowing for high viral titres from eggs. Mutant HA plasmids were 404 
generated by site directed mutagenesis. Viruses were attempted to be rescued a minimum 405 
of three independent times and left for 7 days post-co-culture before being determined to 406 
be un-rescuable. All amino acid differences between the three representative strains, at HA 407 
positions in the vicinity of the receptor binding site, were tested as mutations capable of 408 
influencing binding phenotype. A list of viruses used in this study can be found in Table 6. 409 
Virus sequencing 410 
Viruses were sequenced to confirm no reversions or additional substitutions had 411 
occurred upon production and propagation. The HA1 region of HA was sequenced for each 412 
virus as previously described (40). 413 
Virus purification 414 
Low speed centrifugation was initially used to remove large debris from virus 415 
containing egg allantoic fluid. Virus particles were next pelleted by ultracentrifugation at 416 
27,000rpm for 2 hours. Virus pellets were subsequently homogenised by glass homogeniser, 417 
resuspended and purified with a 30-60% sucrose gradient. The visible band containing virus 418 
was then isolated, diluted into PBS and centrifuged for another 2 hours at 27,000rpm. The 419 
final virus pellet was then resuspended in PBS, 0.01% azide. Concentration of purified 420 
viruses was determined using a nucleoprotein ELISA as described previously (41). 421 
Biolayer interferometry 422 
Purified virus binding to different sialylated receptor analogues was tested using an 423 
Octet RED bio-layer interferometer (Pall ForteBio) as described previously (18). Receptor 424 
analogues contained 30kDa polyacrylamide backbones conjugated to 20 mol % 425 
trisaccharides and 5 mol % biotin (Lectinity Holdings). The three analogues used in this study 426 
were α2,6-sialyllactosamine (6SLN), α-2,3-sialyllactosamine (3SLN) and Neu5Ac α-2,3Galβ1-427 
4(6-HSO3)GlcNAc(3SLN(6su)). Sialoglycopolyemers were bound onto streptavidin coated 428 
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biosensors (Pall ForteBio) at ranges of concentrations from 0.01-0.55µg/ml in 10mM HEPES, 429 
pH 7.4, 150mM NaCl, 3mM EDTA, 0.005% Tween-20 (HBS-EP). Virus was diluted to a 430 
concentration of 100pM in HBS-EP, 10µM oseltamavir carboxylate (Roche), 10µM zanamivir 431 
(GSK). Virus association to the bound sialoglcopolymers was measured at 20oC for 30 432 
minutes. Virus binding curves were normalised to fractional saturation and plotted as a 433 
function of sugar loading. Relative dissociation constants were calculated as described 434 
previously (18, 25). 435 
Modelling of potential receptor binding residues 436 
To identify amino acid positions where substitutions correlated with differences in 437 
receptor-binding avidity apparent in HI titres, a modelling approach previously used to 438 
identify substitutions causing antigenic differences among influenza viruses was adapted 439 
(29, 33, 42, 43). Branches of the HA phylogenetic tree correlated with variation in HI titres 440 
when the branch 1) separated test virus and antisera, 2) descended the test virus, or 3) 441 
descended the virus used to generate antisera. These phylogenetic terms are interpreted as 442 
being associated with changes in 1) antigenicity, 2) receptor-binding avidity, and 3) 443 
immunogenicity, respectively. Internal branches of the phylogeny descending clades of two 444 
or more test viruses associated with systematically higher or lower titres and containing at 445 
least one virus also used as an antisera strain were removed, effectively dropping any terms 446 
from the model that explained variation in HI associated with differences in virus avidity. In 447 
their place, terms representing amino acid identity in the assayed virus at each variable HA 448 
position were tested. At each position, these terms allowed for titres to vary according to 449 
which amino acid residue the virus possessed to account for potential differences in 450 
contributions to avidity. These position-specific terms were added to the model under a 451 
forward selection procedure until the addition of further terms ceased to improve the 452 
model, as assessed by likelihood ratio test (p < 0.05) with a Holm-Bonferroni correction for 453 
multiple testing. At selected positions, effect sizes were estimated for each alternative 454 
amino acid relative to the amino acid found most commonly in the dataset. 455 
Prediction of receptor binding profiles from sequence 456 
All available HA sequences from H9 viruses were downloaded from GIASID. A 457 
phylogenetic tree was generated from aligned nucleotide sequences using MEGA. Receptor-458 
binding profiles were predicted across the phylogeny according to amino acid identify at 459 
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positions 190, 226, and 227 on the basis of the BLI results derived during this study, which in 460 
turn build upon variation at these HA positions in sequences of natural viruses isolated from 461 
different species that varied in receptor-binding preferences as determined in a previous 462 
study (18). Viruses were predicted to exhibit preference for the sulphated avian-like 463 
receptor if at positions 190-226-227 they possessed the motifs A-L-I, A-L-L, A-L-M, A-L-Q, A-464 
Q-I, A-Q-T, I-Q-F, T-L-I, V-L-I (or with reduced confidence T-L-L, T-L-M, T-L-Q, V-L-L, V-L-M, or 465 
V-L-Q), for any avian-like receptor if they possessed the motifs E-Q-L or E-Q-Q, and for the 466 
human-like receptor if they possessed A-Q-Q, D-Q-Q, E-L-Q (or with reduced confidence T-467 
Q-Q or V-Q-Q). Predictions made with reduced confidence indicate that we have not tested 468 
the exact combination of amino acids but that the prediction is consistent with other 469 
combinations barring unforeseen interactions between sites. For viruses with incomplete 470 
sequence information at positions 190, 226 and 227 or alternative motifs, no prediction was 471 
made. Substitutions at positions 196 and 198 that increased relative 6SLN binding were not 472 
included as it is not known which other substitutions must occur to elevate 6SLN binding 473 
above binding for the avian receptor. 474 
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Table 1. Haemagglutinin amino acid differences modulating preference for sulphated (3SLN(6su)) and non-664 
sulphated (3SLN) avian-like receptor. 665 
  
 




Residue (H3 no) Residue (H9 no) WT Virus Substitution 3SLN(6su) 3SLN 6SLN 
190 180 UDL1/08 A->E DNR DNR DNR 
  Em/R66 E->A + + - - null 
226 216 UDL1/08 L->Q + ++ ++ 
  Em/R66 Q->L - --- +++ 
227 217 UDL1/08 I->L + null ++ 
  Em/R66 L->I - - null 
190/226 180/216 UDL1/08 A->E, L->Q - - + - 
  Em/R66 E->A, Q->L = - - - + 
190/226/227 180/216/217 UDL1/08 A->E, L->Q, I->L - - + - 
  Em/R66 E->A, Q->L, L->I - - - - null 
’=’ indicates <2 fold difference, ‘+/-‘ indicates 2-10 fold increase/decrease, ‘++/- -‘ indicates 10-100-fold 666 
increase/decrease, ‘+++/- - -‘ indicates >100-fold increase/decrease in binding relative to the wild type virus. 667 
‘null’ indicates no difference was able to be seen because no binding to this analogue was detected with or 668 























Table 2. Attempted mutants that were not rescued or that were only rescued with compensatory 682 
changes or additional directed mutagenesis or showed a reversion. 683 





UDL1/08 A190E no n/a Yes, L226Q, I227I or I227Q n/a 
UDL1/08 A190D yes n/a n/a Yes, D190G 
(mixed, equal) 
HK/33982 D190A yes Yes, G225D (total 
changea) 
n/a n/a 
HK/33982 Q226L yes Yes, H184E (total 
change) 
n/a n/a 
HK/33982 G225D No n/a Yes, D190A n/a 
HK/33982 
D190A/Q226L 
No n/a n/a n/a 
HK/33982 
D190A/Q226L/Q227I 
No n/a n/a n/a 
































Table 3. Haemagglutinin amino acid differences modulating preference for avian and human-like receptors. 706 
  
 









Substitution 3SLN(6su) 3SLN 
6SLN 
184 174 HK/33982 H->E - - - - - - 
188 178 UDL1/08 D->Y +++ + ++ 
  HK/33982 Y->D - - = 
190 180 UDL1/08 A->D/G = null = 
  HK/33982 D->A DNR DNR DNR 
193 183 UDL1/08 N->T = null + 
  HK/33982 T->N + = = 
196 186 UDL1/08 T->K - - null + + 
225 215 HK/33982 G->D DNR DNR DNR 
226 216 UDL1/08 L->Q + ++ ++ 
227 217 UDL1/08 I->Q = null + + 
  HK/33982 Q->I - - - - - - 
184/226 174/216 HK/33982 Q->L, H->E - - - - - = 
190/225 180/215 HK/33982 D->A, G->D = - - - + 
190/226 180/216 UDL1/08 A->D, L->Q - - - null - 
  HK/33982 D->A, Q->L DNR DNR DNR 
190/227 180/217 UDL1/08 A->D, I->Q - - - null + + 
  HK/33982 D->A, Q->I + + - - - - 
190/226/227 180/216/217 UDL1/08 A->D, L->Q, I->Q - - - null = 
  HK/33982 D->A, Q->L, Q->I DNR DNR DNR 
’=’ indicates <2 fold difference, ‘+/-‘ indicates 2-10 fold increase/decrease, ‘++/- -‘ indicates 10-100-fold 707 
increase/decrease, ‘+++/- - -‘ indicates >100-fold increase/decrease in binding relative to the wild type virus. 708 
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‘null’ indicates no difference was able to be seen because no binding to this analogue was detected with or 709 




Table 4. Amino acid residues predicted to explain variation in HI titres as a result differences in 714 









Effect on 3SLN(6su) 
bindinga 
190 180 A 1,145 - 
T 309 50x increase 
V 494 1400x increase 
196 186 T 1,912 - 
I 331 41x decrease 
K 296 7x decrease 
198 188 T 1,913 - 
A 351 41x decrease 
aEffect on 3SLN(6su) binding is shown relative to most common amino acid in meta-analysis dataset: 716 


























Table 5. Amino acid motifs across positions 190, 226 and 227 and accompanying 733 
prediction of receptor-preference. 734 
Amino acid residue (H9 numbering in 
brackets) 
Predicted receptor preference 
190 (180) 226 (216) 227 (217)  
A/T/V L I/L/M/Q Avian-like (sulphated) 
A Q I/T Avian-like (sulphated) 
I Q F Avian-like (sulphated) 
E Q L/Q Avian-like (non-sulphated or sulphated)  
A/D/T/V Q Q Human-like 
E L Q Human-like 
Where alternative motifs were present or sequence data at these positions was incomplete, 735 





























Table 6. Full list of viruses rescued (or attempted) in this study.  755 





UDL1/08 R82G R74G  
 T135K T129K  
 K137I K131I  
 F147L F137L  
 T155I T145I  
 K157T K147T  
 N158D N148D  
 G159K G149K  
 D188Y D178Y  
 N189T N179T  
 A190E A180E DNR 
 A190D A180D Partly reverted to 
D190G 
 T192R T182R  
 N193D N183D  
 N193T N183T  
 T196I T186I  
 T196K T186K  
 T198A T188A  
 G225D G215D  
 L226Q L216Q  
 I227L I217L  
 I227Q I217Q  
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 I227M I217M  
 A190E/L226Q A180E/L216Q  
 A190D/I227Q A180D/I217Q  
 A190E/L226Q/I227L A180E/L216Q/I217L  
 A190D/L216Q/I227Q A180D/L216Q/I217Q  
Em/R66 E190A E180A  
 Q226L Q216L  
 L227I L217I  
 E190A/Q226L E180A/Q216L  
 E190A/L227I E180A/L217I  
 E190A/Q226L/L227I E180A/Q216L/L217I  
HK/33982 H184E H174E Compensatory 
mutation of Q226L 
 Y188D Y178D  
 D190A D180A Got compensatory 
mutation G225D 
upon rescue 
 T193N T183N  
 G225D G215D DNR 
 Q226L Q216L Got compensatory 
mutation H184E 
upon rescue 
 Q227I Q217I  
 D190A/Q226L D180A/Q216L DNR 
 D190A/Q227I D180A/Q217I  
 D190A/Q226L/Q227I D180A/Q216L/Q217I DNR 



















Figure 1 – Varying receptor binding profiles of naturally occurring viruses. Biolayer 765 
interferometry was used to determine the receptor binding profiles of H9N2 viruses 766 
UDL1/08 (Panel A), Em/R66 (B), and HK/33982 (C). Binding was measured to three receptor 767 
analogues representative of: 1) an avian-like receptor (α2,3-sialyllactosamine or 3SLN, red 768 
lines), 2) a sulphated avian-like receptor (Neu5Ac α2,3 Gal β1-4(6-HSO3)GlcNAc or 769 
3SLN(6su), green lines), and 3) a human-like receptor (α2,6-sialyllactosamine or 6SLN, blue 770 
lines). Where no binding was observed, the lines are omitted. Sequence differences in HA 771 
between UDL1/08 and Em/R66 (D) shown in blue and between UDL1/08 and HK/33982 (E) 772 
shown in yellow. Selected receptor binding residues shown in red. Figure made using 773 
structure PDBID:1JSH (44), made using PyMol (45). 774 
Figure 2 - Receptor binding profiles of reciprocal UDL1/08-Em/R66 mutants. Biolayer 775 
interferometry was used to determine the receptor binding profiles mutant UDL1/08 776 
(Panels A-C, UDL1/08 A190E could not be rescued) and Em/R66 viruses (panels D-F). Binding 777 
was measured to 3 receptor analogues: Neu5Ac α2,3 Gal β1-4(6-HSO3)GlcNAc (3SLN(6su), 778 
Panels A,D), α2,6-sialyllactosamine (6SLN, Panels B,E) and α2,3-sialyllactosamine (3SLN, 779 
Panels C,F). Dashed black and red lines show wild-type UDL1/08 and Em/R66 binding, 780 
respectively. Summary of data shown in Table 3. 781 
Figure 3. Receptor binding profiles of reciprocal UDL1/08-HK/33982 mutants Biolayer 782 
interferometry was used to determine the receptor binding profiles mutant UDL1/08 783 
(Panels A-C) and HK/33982 viruses (panels D-F). Binding was measured to 3 receptor 784 
analogues: Neu5Ac α2,3 Gal β1-4(6-HSO3)GlcNAc (3SLN(6su), Panels A,D), α2,6-785 
sialyllactosamine (6SLN, Panels B,E) and α2,3-sialyllactosamine (3SLN, Panels C,F). Dashed 786 
black and green lines show wild-type UDL1/08 and HK/33982 binding, respectively. 787 
Summary of data shown in Table 4. 788 
 789 
Figure 4. Receptor binding modulation by non-reciprocal mutations in the background of 790 
UDL1/08. Biolayer interferometry was used to determine the receptor binding profiles of 791 
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each mutant virus. Binding was measured to 3 receptor analogues, α2,6-sialyllactosamine 792 
(6SLN), α2,3-sialyllactosamine (3SLN) and Neu5Ac α2,3 Gal β1-4(6-HSO3)GlcNAc 793 
(3SLN(6su)). No viruses had any detectable 3SLN binding. Dashed black lines show wild-type 794 
UDL1/08 binding. Panels indicate binding by mutants that show an avidity reduction (A,B), 795 
an increase in avidity (C,D) and changes in receptor binding preference (E,F). No mutants 796 
had any detectable binding to 3SLN. 797 
 798 
Figure 5 - Mapping of residues tested for receptor binding changes and correlation 799 
between charge and 3SLN(6su) binding. A) The fold-increase in binding to 3SLN(6su) is 800 
plotted along with the introduced change in net charge difference. Wild type UDL1/08 801 
binding to 3SLN(6su) is set to 1 with relative binding calculated as described previously (18). 802 
Annotated P values calculated using a non-parametric Mann-Whitney U test – lines indicate 803 
mean fold increase. B) Residues which effect receptor binding preference (i.e. effect binding 804 
to different analogues in different ways) shown in red, residues that affect receptor binding 805 
avidity across analogues shown in orange. Residue that when mutated have no effect on 806 
receptor binding shown in green. LSTa, shown in yellow, is an α2,3-linked (avian-like) 807 
receptor analogue. H3 HA numbering used throughout. Figure made using structure 808 
PDBID:1JSH (44), using PyMol (45). 809 
Figure 6. Sequence variation and predicted receptor preference across H9N2 phylogeny. 810 
HA phylogeny for 2,440 H9N2 viruses rooted with a sequence from H9-like bat influenza 811 
virus (marked with X). Amino acid identity at positions 190, 226 and 217 is shown by colour, 812 
grouped by side-chain property, according to the legend. The receptor-binding preference 813 
of viruses was predicted as being for either the sulphated avian-like receptor (green), non-814 
specific avian-like receptor (sulphated or non-sulphated, red) or for the human-like receptor 815 
(blue), with lighter shades indicating reduced confidence (details in Materials and Methods). 816 
Predicted receptor preference is based on amino acid identity at positions 190, 226 and 227 817 
from extrapolation of testing of viruses generated in mutagenesis experiments using 818 
biolayer interferometry with a range of receptor analogues. 819 
 820 
 821 
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